Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0252 | ||||
Gene Name | SLC2A10 | ||||
Protein Name | Glucose transporter type 10 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | ATORS; ATS; GLUT-10; GLUT10; SLC2A10; Solute carrier family 2, facilitated glucose transporter member 10 | ||||
DT Family | Major Facilitator Superfamily (MFS) | ||||
Sugar Porter (SP) Family | |||||
Tissue Specificity | Widely expressed; highest levels in liver andpancreas. | ||||
Function | This transporter facilitates glucose transporter. | ||||
Endogenous Substrate(s) | Glucose | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
2-Deoxyglucose
|
Phase 1/2 | Drug Info | Cancer | 2A00-2F9Z | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 2 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Bile acid unspecific | N.A. | EM Info | Identified using GLUT10 homology model | [2] | |
Lipid unspecific | N.A. | EM Info | Identified using GLUT10 homology model | [2] | |
Drug-DT Affinity Assessed by Cell Line |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
2-Deoxyglucose | Phase 1/2 | Drug Info | Xenopus oocytes-GLUT10 | Km = 300 microM | [1] |
References | |||||
1 | Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. Mol Genet Metab. 2001 Sep-Oct;74(1-2):186-99. | ||||
2 | Comprehensive in silico Study of GLUT10: Prediction of Possible Substrate Binding Sites and Interacting Molecules. Curr Pharm Biotechnol. 2019 Jun 13. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.